Institutional Ownership
Enlivex Therapeutics Ltd
CUSIP M4130Y106COMQ1 2026
Institutional Holders
35
13F filers
Shares Held
3.64M
Aggregate institutional
Institutional Value
$3.33M
Q1 2026
Net New Holders
+10
13 new · 3 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions13
Increased8
Decreased6
Sold out3
Institutional Holders
35 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Diametric Capital, LP | 1.48M | $1.38M | +1.48M | New |
| 2 | Ark Investment Management LLC | 628.3K | $584.4K | +628.3K | New |
| 3 | Prelude Capital Management, LLC | 225.7K | $210.0K | +225.7K | New |
| 4 | Two Sigma Investments, LP | 146.4K | $136.2K | −48.7K | Reduced |
| 5 | Ubs Group AG | 138.3K | $128.6K | +103.3K | Added |
| 6 | Bank Of America Corp /De/ | 130.4K | $121.3K | +45.3K | Added |
| 7 | Renaissance Technologies LLC | 128.2K | $119.2K | −185.4K | Reduced |
| 8 | Jpmorgan Chase & Co | 125.9K | $113.4K | +123.8K | Added |
| 9 | Goldman Sachs Group Inc | 102.1K | $95.0K | +102.1K | New |
| 10 | Xtx Topco Ltd | 100.4K | $93.3K | +38.6K | Added |
25 more institutional holders on Premium
See every fund holding Enlivex Therapeutics Ltd, with full quarter-over-quarter share changes.
Unlock all holders